Wall Street Investors Turn to Biotechnology Industry

Investors increasingly are looking toward the biotechnology industry in the wake of the country's financial troubles. To some extent, biomedical firms have been unaffected by the constraint on business financing because large pharmaceutical firms have been serving in the role of the banking industry in recent years.

• "Tech, Biotech Offer Safe Havens for Investors" (Tansey, San Francisco Chronicle, 9/17).